Optineurin Gene Expression Level in Human Trabecular Meshwork Does Not Change in Response to Pressure ElevationKamphuis W. · Schneemann A.
Netherlands Ophthalmic Research Institute–KNAW, Glaucoma Research Group, Amsterdam, The Netherlands
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Mutations in the gene optineurin (OPTN) have been associated with primary-open angle glaucoma. Here we present a study on the level of OPTN gene expression in the human trabecular meshwork in response to increased perfusion pressure in the anterior chamber perfusion model of the human eye. Perfusion pressure was raised from 10 to 30 mm Hg for periods ranging between 1 and 24 h. OPTN transcript levels in the trabecular meshwork were determined using real-time quantitative polymerase chain reaction. The results show no statistically significant alteration of the OPTN transcript level after raising the pressure. Moreover, no changes were detected in the transcript levels of the 3 known OPTN isoforms. This result shows that enhanced pressure levels do not lead to rapid changes in gene expression levels of OPTN in human trabecular meshwork. This suggests that alterations in OPTN gene expression are not involved in the mechanisms regulating aqueous humor outflow after an increase in intraocular eye pressure.
© 2003 S. Karger AG, Basel
- Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M: Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295:1077–1079.
- Li Y, Kang J, Horwitz MS: Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 1998;18:1601–1610.
- Schwamborn K, Weil R, Courtois G, Whiteside ST, Israel A: Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in an NF-kappa B-independent pathway. J Biol Chem 2000;275:22780–22789.
- Coleman AL: Glaucoma. Lancet 1999;354:1803–1810.
Bill A: Some aspects of aqueous humour drainage. Eye 1993;7:14–19.
Schneemann A, Hoyng PFJ, Kamphuis W: Effects of elevated pressure on prostanoid-receptor gene expression levels in human trabecular meshwork. Ophthalmic Res 2002;34:314–318.
- Gonzalez P, Epstein DL, Borrás T: Genes upregulated in the human trabecular meshwork in response to the elevated intraocular pressure. Invest Ophthalmol Vis Sci 2000;41:352–361.
- Borras T, Rowlette LL, Tamm ER, Gottanka J, Epstein DL: Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Invest Ophthalmol Vis Sci 2002;43:33–40.
- Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169–193.
- Dijkstra BG, Schneemann A, Hoyng PF: Flow after prostaglandin E1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments. Invest Ophthalmol Vis Sci 1999;40:2622–2626.
- Dijkstra BG, Ruijter JM, Hoyng PF: Outflow characteristics of isolated anterior segments of human eyes. Invest Ophthalmol Vis Sci 1996;37:2015–2021.
- Kamphuis W, Schneemann A, Van Beek LM, Smit AB, Hoyng PF, Koya E: Prostanoid receptor gene expression profile in human trabecular meshwork: A quantitative real-time PCR approach. Invest Ophthalmol Vis Sci 2001;42:3209–3215.
- Freeman WM, Walker SJ, Vrana KE: Quantitative RT-PCR: Pitfalls and potential. Biotechniques 1999;26:112–115.
- Vittitow JL, Borrás T: Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure. Biochem Biophys Res Commun 2002;298:67–74.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.